ID: ALA4847846

Max Phase: Preclinical

Molecular Formula: C36H46N3O7P

Molecular Weight: 663.75

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCC(C)C(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C)P(=O)(Oc1ccccc1)Oc1ccccc1

Standard InChI:  InChI=1S/C36H46N3O7P/c1-6-26(2)33(47(43,45-28-19-12-8-13-20-28)46-29-21-14-9-15-22-29)38-32(40)30-23-16-24-39(30)34(41)31(36(3,4)5)37-35(42)44-25-27-17-10-7-11-18-27/h7-15,17-22,26,30-31,33H,6,16,23-25H2,1-5H3,(H,37,42)(H,38,40)/t26?,30-,31+,33?/m0/s1

Standard InChI Key:  AEZNOQJIMPKOLO-BEMTXIMASA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Probable periplasmic serine endoprotease DegP-like 58 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Chlamydia trachomatis 699 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Chlamydia pecorum 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 663.75Molecular Weight (Monoisotopic): 663.3073AlogP: 7.16#Rotatable Bonds: 13
Polar Surface Area: 123.27Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.91CX Basic pKa: CX LogP: 7.05CX LogD: 7.05
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.19Np Likeness Score: -0.21

References

1. Hwang J, Strange N, Phillips MJA, Krause AL, Heywood A, Gamble AB, Huston WM, Tyndall JDA..  (2021)  Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.,  224  [PMID:34265463] [10.1016/j.ejmech.2021.113692]

Source